| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. | J Clin Oncol | 2005 | 2.47 |
| 2 | Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy. | Head Neck | 2011 | 1.05 |
| 3 | Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study. | Cancer Chemother Pharmacol | 2008 | 0.79 |
| 4 | Assessment of ERCC1 and XPF protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients undergoing curative intent treatment. | Int J Radiat Oncol Biol Phys | 2012 | 0.79 |